Rafael Jose
Ruiz Salmeron
Consultor Médico
Hospital Vall d'Hebron
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (9)
2023
-
Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)
Cardiovascular Diagnosis and Therapy, Vol. 13, Núm. 5
2022
-
Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry
Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487
2020
-
Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience
Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002
2017
-
A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)
EuroIntervention, Vol. 12, Núm. 13, pp. 1587-1594
2016
-
Puncture Versus Surgical Cutdown Complications of Transfemoral Aortic Valve Implantation (from the Spanish TAVI Registry)
American Journal of Cardiology, Vol. 118, Núm. 4, pp. 578-584
2014
-
Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: A randomized controlled clinical trial
International Journal of Cardiology, Vol. 177, Núm. 3, pp. 935-941
-
Randomized comparison between polymer-free versus polymer-based paclitaxel-eluting stent two-year final clinical results
Circulation: Cardiovascular Interventions, Vol. 7, Núm. 3, pp. 312-321
2013
-
In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011
Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958
2012
-
Double antiplatelet therapy after drug-eluting stent implantation: Risk associated with discontinuation within the first year
Journal of the American College of Cardiology, Vol. 60, Núm. 15, pp. 1333-1339